
Koninklijke Philips N.V. PHG
€ 23.15
-0.79%
Geschäftsbericht 2024
hinzugefügt 06.12.2025
Koninklijke Philips N.V. EV 2011-2026 | PHG
EV Jährlich Koninklijke Philips N.V.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.5 B | 15.5 B | -1.17 B | 28.5 B | 61.9 B | 63.6 B | 58.9 B | 55.8 B | 68.7 B | 69.2 B | 73.7 B | 58.5 B | 23.7 B | 29.4 B |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 73.7 B | -1.17 B | 44.3 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
223 M | $ 19.0 | 0.11 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 20.8 | 0.85 % | $ 226 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 0.17 | -5.26 % | $ 4.99 M | ||
|
BioNano Genomics
BNGO
|
35.7 M | $ 1.52 | 1.2 % | $ 1.93 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 39.06 | -0.64 % | $ 1.08 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Danaher Corporation
DHR
|
150 B | $ 229.23 | -0.65 % | $ 168 B | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 10.98 | 2.62 % | $ 312 M | ||
|
DexCom
DXCM
|
52.4 B | $ 66.52 | -0.81 % | $ 25.7 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
12.2 B | $ 101.86 | -0.04 % | $ 18.9 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 26.19 | -1.13 % | $ 792 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
644 M | $ 18.93 | -0.73 % | $ 1.02 B | ||
|
Celcuity
CELC
|
506 M | $ 99.58 | -0.34 % | $ 3.93 B | ||
|
Anixa Biosciences
ANIX
|
1.5 M | $ 3.13 | 0.32 % | $ 99.8 K | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
6.94 B | $ 102.21 | 1.6 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
IQVIA Holdings
IQV
|
54.8 B | $ 225.57 | -0.92 % | $ 40.9 B | ||
|
ENDRA Life Sciences
NDRA
|
864 K | $ 4.45 | -6.62 % | $ 2.39 M | ||
|
Illumina
ILMN
|
15.3 B | $ 130.74 | -1.51 % | $ 20.8 B | ||
|
Charles River Laboratories International
CRL
|
12.4 B | $ 200.01 | -0.93 % | $ 10.3 B | ||
|
Quidel Corporation
QDEL
|
460 M | $ 28.49 | -2.76 % | $ 1.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 173.69 | -1.03 % | $ 19.3 B | ||
|
Biodesix
BDSX
|
142 M | $ 6.75 | 0.45 % | $ 875 M | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
29.9 B | $ 251.26 | -0.72 % | $ 21.1 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 181.71 | -0.7 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
39.1 B | $ 676.07 | -0.92 % | $ 55.8 B | ||
|
Lantheus Holdings
LNTH
|
6.44 B | $ 66.81 | -0.52 % | $ 4.62 B | ||
|
Mettler-Toledo International
MTD
|
33.2 B | $ 1 396.59 | -1.25 % | $ 29.6 B | ||
|
Agilent Technologies
A
|
45.8 B | $ 136.49 | -0.81 % | $ 41.5 B | ||
|
Myriad Genetics
MYGN
|
1.2 B | $ 6.12 | -0.89 % | $ 554 M | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.5 | 2.04 % | $ 5.74 M | ||
|
Bioventus
BVS
|
904 M | $ 7.44 | -0.13 % | $ 466 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | $ 45.03 | -0.64 % | $ 10 B | ||
|
NeoGenomics
NEO
|
1.9 B | $ 11.82 | -3.35 % | $ 1.5 B |